UPDATE – OptimizeRx Reports Strong Fourth Quarter and Full Year 2025 Financial ResultsGlobeNewsWire • 03/05/26
OptimizeRx Reports Strong Fourth Quarter and Full Year 2025 Financial ResultsGlobeNewsWire • 03/05/26
OptimizeRx Sets Fourth Quarter and Full Year 2025 Financial Results Conference Call for March 5, 2026, at 4:30 p.m. ETGlobeNewsWire • 02/05/26
Strength Seen in OptimizeRx (OPRX): Can Its 7.5% Jump Turn into More Strength?Zacks Investment Research • 02/05/26
OptimizeRx and Experian Collaborate to Improve Privacy-Safe Identity Resolution in Healthcare MarketingGlobeNewsWire • 01/07/26
OptimizeRx Stock: A Buy-The-Dip Opportunity For This Above-Average Growth StorySeeking Alpha • 12/23/25
OptimizeRx Reports Third Quarter 2025 Financial Results and Increases Fiscal Year 2025 GuidanceGlobeNewsWire • 11/06/25
OptimizeRx Sets Third Quarter 2025 Conference Call for November 6, 2025, at 4:30 p.m. ETGlobeNewsWire • 10/20/25
OptimizeRx Corp. (OPRX) is a Great Momentum Stock: Should You Buy?Zacks Investment Research • 10/02/25
OptimizeRx Bets on AI and Workflow Integration - Will This Pay Off?Zacks Investment Research • 09/30/25
OptimizeRx to Participate in the 9th Annual Lake Street Capital Best Ideas Growth ConferenceGlobeNewsWire • 09/10/25
OptimizeRx Partners with Lamar Advertising to Reach Clinically Relevant Audiences Through Out-of-Home Healthcare AdvertisingGlobeNewsWire • 09/09/25
What Makes OptimizeRx Corp. (OPRX) a Strong Momentum Stock: Buy Now?Zacks Investment Research • 09/01/25
All You Need to Know About OptimizeRx (OPRX) Rating Upgrade to Strong BuyZacks Investment Research • 08/21/25
OptimizeRx Corporation Announces Leadership Team Advancements to Accelerate Strategic GrowthGlobeNewsWire • 08/19/25
OptimizeRx Corp. (OPRX) Surpasses Q2 Earnings and Revenue EstimatesZacks Investment Research • 08/07/25